Cargando…

Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome

OBJECTIVE: Kisspeptin 1 might reflect increased androgen level in polycystic ovarian syndrome instead of other markers. Study Design. A case control study was performed in Al-Yarmouk Teaching Hospital from 1(st) of July 2016 to 1(st) of July 2017; it involved 87 women divided into two groups: 44 wom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdalqader, Manal Madany, Hussein, Shatha Sami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533004/ https://www.ncbi.nlm.nih.gov/pubmed/33061987 http://dx.doi.org/10.1155/2020/5216903

Ejemplares similares

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain
por: Golbahar, Jamal, et al.
Publicado: (2012)

Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls
por: Chappell, Neil Ryan, et al.
Publicado: (2020)

Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome
por: Harris, R. Alan, et al.
Publicado: (2023)

Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Shan, Chang, et al.
Publicado: (2022)

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
por: Ozegowska, Katarzyna, et al.
Publicado: (2020)

A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor
por: Roozbeh, Jamshid, et al.
Publicado: (2022)

Inflammatory Markers in Women with Polycystic Ovary Syndrome
por: Rudnicka, E., et al.
Publicado: (2020)

The Effect of Short-term Treatment with Metformin on Insulin Resistance among Obese Iraqi Women with Polycystic Ovary Syndrome
por: Findakly, Sura Basil, et al.
Publicado: (2021)

Effects of KISS1 structural polymorphism on the risk of polycystic ovary syndrome and reproductive hormones in Iraqi women who take metformin
por: Kadhem, Ali Hakem, et al.
Publicado: (2023)

The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
por: Valderhaug, T.G., et al.
Publicado: (2015)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

Study of early atherosclerotic markers in women with polycystic ovary syndrome
por: Karoli, Ritu, et al.
Publicado: (2012)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome
por: Rahiminejad, Mohammad Ehsan, et al.
Publicado: (2014)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Postmenopausal women with hyperandrogenemia: Three case reports
por: Zhu, Xiao-Dan, et al.
Publicado: (2021)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Polycystic ovary syndrome and circulating inflammatory markers
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2017)

Hepatic steatosis in women with polycystic ovary syndrome
por: Hong, Xinyu, et al.
Publicado: (2023)

Diagnosis of Sertoli-Leydig Cell Tumor of the Ovary Complicated by the Pattern of Hyperandrogenemia and Results of Imaging
por: Jaju, Amruta, et al.
Publicado: (2021)

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue
por: Zhang, Yahui, et al.
Publicado: (2023)

Autonomic dysfunction in women with polycystic ovary syndrome
por: Hashim, Zainab Hasan, et al.
Publicado: (2015)

An overview of polycystic ovary syndrome in aging women
por: Çelik, Özlem, et al.
Publicado: (2021)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Anxiety and Depression in Women with Polycystic Ovary Syndrome
por: Dybciak, Paweł, et al.
Publicado: (2022)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
por: Jena, Sweekruti, et al.
Publicado: (2023)

Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome
por: YETİM ŞAHİN, Aylin, et al.
Publicado: (2019)

Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report
por: Adefris, Mulat, et al.
Publicado: (2017)

Serum adiponectin in Indian women with polycystic ovary syndrome
por: Rajendra, Aishwarya, et al.
Publicado: (2023)

Adrenal myelolipoma with hyperandrogenemia and schizophrenia
por: Liu, Ningning, et al.
Publicado: (2018)

Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine
por: Mohamadin, Ahmed M., et al.
Publicado: (2010)

Inter-ovarian differences in ultrasound markers of ovarian size in women with polycystic ovary syndrome
por: Chun, Sungwook
Publicado: (2019)

Peripheral hematological parameters in women with polycystic ovary syndrome
por: ALhabardi, Nadiah A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7vei5ek13if6b7nast4f8bgj8f